Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The study found that thioglycolic acid breaks down hair bonds more consistently than l-cysteine, which is less damaging to hair.

Minoxidil detects nitrite in water, creating a simple, cheap test.

QSOX enzymes help form protein bonds in cells, especially in tissues with high secretory activity.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

LH and hCG reduce certain protein levels in women's skin.

The new hair product quickly reduces hair shedding in women.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

The study created a new method to test drugs that affect hormone processing in skin.

The new method for making Finasteride is cheaper and safer for large-scale production.

Nucleophilic reagents break down hair keratin, forming more lanthionine and lysinoalanine than in wool.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Small KP peptide improves hair without reducing agents, while larger proteins need them for better results.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

The protein's size was reduced, but more work is needed to confirm its function.

Depilatories use chemicals to weaken hair for easy removal.

Type 2 5α-reductase plays a key role in hair loss.